PsyBio Therapeutics Reports Interim Third Quarter 2022 Financial Results – PsyBio Therapeutics (OTC:PSYBF)
PsyBio Therapeutics Corp. PSYB PSYBF reported its unaudited interim financial results for the three and nine-month period ended September 30, 2022. PsyBio, a fully integrated and intellectual property-driven biotechnology company, develops new…